EverlyWell Stock

everlywell.comDigital HealthFounded: 2015Funding to Date: $531.1MM

Everlywell is the developer of a comprehensive tests designed to measure key biomarkers through samples that are collected in the comfort of your home.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for EverlyWell, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Julia Cheek
Founder & Chief Executive Officer
Joshua Stanley
Chief Financial Officer
Nick Parker
Chief Technology Officer
Jenifer Dasho
Chief Marketing Officer
Matthew Carroll
Vice President of Marketing

Board Members

Michael Smerklo
Next Coast Ventures

Other companies like EverlyWell in the Digital Health sector

Sector
Last Round Est. Valuation
$1.6B
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$2B
Sector
Last Round Est. Valuation
$5.25B
Sector
Last Round Est. Valuation
$2B
Sector
Last Round Est. Valuation
$1.81B
Sector
Last Round Est. Valuation
$278.64MM
Sector
Last Round Est. Valuation
$170MM
Sector
Last Round Est. Valuation
$780.77MM

News

Everlywell, a Texas-based producer of home tests for COVID-19 and other diseases and conditions, has raised $75 million on top of a recent $175 million round.
At-home health testing kit startup Everlywell has raised $75 million, following the close of the $175 million Series D it announced in December. The new funding comes from HealthQuest Capital, and sees the fund’s founder and managing partner Dr. Garheng Kong join the company’s board of …
With the new investment, CEO Julia Cheek confirmed the company’s valuation at $1.3 billion.